Literature DB >> 7907607

MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.

A Pich1, R Ponti, G Valente, L Chiusa, M Geuna, D Novero, G Palestro.   

Abstract

AIMS: To verify the correlation between MIB-1, Ki67, and proliferating cell nuclear antigen (PCNA-PC10) scores and S-phase fraction in intermediate grade non-Hodgkin's lymphomas (Working Formulation F); and their reliability in differently processed tissues.
METHODS: Forty one non-Hodgkin's lymphomas were classified as (F) intermediate grade malignant lymphomas according to the Working Formulation; mitotic counts and percentage of large cells were assessed for each case. Sections from formalin fixed, paraffin wax embedded tissues were stained with anti MIB-1 monoclonal antibody, after microwave oven processing, and anti-PCNA (PC10) monoclonal antibody using an avidin-biotin immunoperoxidase (ABC) method. One thousand cells from 10 representative fields were scored. Frozen sections from surgical specimens were stained with Ki67 monoclonal antibody using the ABC method; the fraction of Ki67 positive cells was calculated scoring 1000 cells. Flow cytometry analysis (FCM) was performed on cell suspensions from fresh tissues. Correlations between data were estimated using linear regression.
RESULTS: A linear correlation was found between MIB-1 and Ki67 scores (r = 0.92; p < 0.00001); between MIB-1 and PCNA scores (r = 0.79; p < 0.00001); and between MIB-1 score and S-phase fraction (r = 0.51; p = 0.0006). A linear correlation was also found between Ki67 and PCNA scores (r = 0.85; p < 0.00001); between Ki67 score and S-phase fraction (r = 0.6; p = 0.0002); and between PCNA score and S-phase fraction (r = 0.74; p < 0.00001). A correlation was found between mitotic counts and MIB-1 (r = 0.56; p = 0.0001), PCNA (r = 0.51; p = 0.0007), or Ki67 scores (r = 0.47; p = 0.002); between the percentage of large cells and MIB-1 (r = 0.49; p = 0.0009), PCNA (r = 0.6; p = 0.00003), and Ki67 scores (r = 0.53; p = 0.0003) and S-phase fraction (r = 0.55; p = 0.0002).
CONCLUSION: MIB-1, Ki67, and PCNA (PC10) scores and S-phase fraction are highly correlated and equally well represent the proliferative activity of intermediate grade non-Hodgkin's lymphomas in differently processed material. MIB-1 and PCNA stains can be applied even on small biopsy specimens. MIB-1 produces homogenous staining without background; it also strongly stains mitotic figures. It can be performed on routinely processed tissues, permitting the simultaneous evaluation of the morphology and tumour cell kinetics. The wide standard deviations of the proliferative indices found for intermediate grade NHL suggest that this category probably includes various degrees of malignancy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7907607      PMCID: PMC501749          DOI: 10.1136/jcp.47.1.18

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  40 in total

1.  Comparison of nuclear DNA content in primary and metastatic differentiated thyroid carcinoma.

Authors:  H Joensuu; P J Klemi
Journal:  Am J Clin Pathol       Date:  1988-01       Impact factor: 2.493

2.  The prognostic significance of proliferative activity in poor histology non-Hodgkin's lymphoma: a flow cytometry study using archival material.

Authors:  G A Young; D W Hedley; C A Rugg; H J Iland
Journal:  Eur J Cancer Clin Oncol       Date:  1987-10

3.  Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.

Authors:  J Gerdes; R J Lelle; H Pickartz; W Heidenreich; R Schwarting; L Kurtsiefer; G Stauch; H Stein
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

4.  Growth fractions in human prostatic carcinoma determined by Ki-67 immunostaining.

Authors:  W A Raymond; A S Leong; J W Bolt; J Milios; J S Jose
Journal:  J Pathol       Date:  1988-10       Impact factor: 7.996

5.  Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis.

Authors:  R L Garcia; M D Coltrera; A M Gown
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

6.  Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma.

Authors:  A Pich; L Chiusa; P Pisani; M Krengli; F Pia; R Navone
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

7.  Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations.

Authors:  N A Shepherd; P I Richman; J England
Journal:  J Pathol       Date:  1988-07       Impact factor: 7.996

8.  Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas.

Authors:  J Crocker; J C Macartney; P J Smith
Journal:  J Pathol       Date:  1988-02       Impact factor: 7.996

9.  Immunohistological determination of proliferative activity in seminomas.

Authors:  W Düe; K P Dieckmann; V Loy
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

10.  The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma.

Authors:  P A Hall; M A Richards; W M Gregory; A J d'Ardenne; T A Lister; A G Stansfeld
Journal:  J Pathol       Date:  1988-03       Impact factor: 7.996

View more
  8 in total

1.  Prognostic value of MIB-1 index and DNA ploidy in resectable ampulla of Vater carcinoma.

Authors:  Y M Shyr; C H Su; L H Wu; A F Li; J H Chiu; C W Wu; W Y Lui
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

2.  The use of enhanced polymer one-step staining reagents for immunoenzyme double-labelling.

Authors:  C M Van der Loos; T Naruko; A E Becker
Journal:  Histochem J       Date:  1996-10

3.  Biological factors, tumor growth kinetics, and survival after metastasectomy for pulmonary melanoma.

Authors:  Jonathan H Lee; Seza A Gulec; Ainura Kyshtoobayeva; Myung-Shin Sim; Donald L Morton
Journal:  Ann Surg Oncol       Date:  2009-07-15       Impact factor: 5.344

4.  Prognostic significance of proliferative activity, DNA-ploidy, p53 and Ki-ras point mutations in colorectal liver metastases.

Authors:  A Russo; M Migliavacca; V Bazan; N Maturi; V Morello; G Dardanoni; G Modica; P Bazan; I Albanese; M La Farina; R M Tomasino
Journal:  Cell Prolif       Date:  1998 Jun-Aug       Impact factor: 6.831

5.  Proliferative activity is a significant prognostic factor in male breast carcinoma.

Authors:  A Pich; E Margaria; L Chiusa
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

6.  Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNA.

Authors:  P J Hepburn; E Glynne-Jones; L Goddard; J M Gee; M E Harper
Journal:  Histochem J       Date:  1995-03

7.  Local macrophage proliferation in multinucleated giant cell and granuloma formation in experimental Goodpasture's syndrome.

Authors:  H Y Lan; D J Nikolic-Paterson; W Mu; R C Atkins
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

8.  Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas.

Authors:  P A Ellis; A Makris; S A Burton; J Titley; M G Ormerod; J Salter; T J Powles; I E Smith; M Dowsett
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.